Skip to content

Chemische Fabrik Budenheim receives EXCiPACT GMP certification

It has been announced that Chemische Fabrik Budenheim site in Budenheim, Germany, has recently been awarded an EXCiPACT GMP/GDP certificate from SGS — one of EXCiPACT’s internationally recognised certification bodies.

Chemische Fabrik Budenheim receives EXCiPACT GMP certification
Published: | 1 min read

It has been announced that Chemische Fabrik Budenheim site in Budenheim, Germany, has recently been awarded an EXCiPACT GMP/GDP certificate from SGS — one of EXCiPACT’s internationally recognised certification bodies.

The certificate demonstrates that the site manufactures pharmaceutical excipients according to EXCiPACT GMP and GDP certification standards. Its scope covers manufacturing, testing, storage and distribution of sodium, magnesium and calcium phosphates for use as pharmaceutical excipients.

EU and US pharmaceutical regulations require all drug manufacturers to wither conduct their own or commission third party physical audits of all their starting material suppliers, in order to demonstrate GMP and/or GDP compliance. Through the EXCiPACT certification scheme, which employs GMP and GDP standards designed for excipients, excipient users and suppliers may reduce their audit burden.

About the author

PharmaManufacturing IQ Staff

An article written by the PharmaManufacturing IQ staff

All articles

Sign up to our newsletter

The week's biggest stories from this industry, direct to your inbox.

Personal information

More in Quality & Validation

See all

More from PharmaManufacturing IQ Staff

See all